Forest Laboratories, Inc.

Forest Laboratories, Inc.

Sector: Pharmaceutical Preparations Region: NY, United States

Similar to: Hutchison China MediTech Ltd., Ipsen SA, Skystar Bio-Pharmaceutical Co.

Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY.

News & Analysis

You may also be interested in: